Project Number T-PEP-20-675711 Agency/Funding Organization Alzheimer's Association|Tau Consortium Funding Year 2020 View Full Project Details for TauC3: a key tauopathy culprit and an antibody to mitigate its effects Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Chain, Daniel Principal Investigator First Name Daniel Principal Investigator Last Name Chain Awardee Organization TauC3 Biologics Limited Contact PI Country United Kingdom Project Detail Funding Opportunity Announcement PA 2020: T-PEP RFA FY Overall Cost $400,000 Funding Organization Agency/Funding Organization Alzheimer's Association|Tau Consortium Program Official Murtishaw, Andrew asmurtishaw@alz.org
